Research Articles on Tuberculosis from 1940 onwards

Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.
Ann Am Thorac Soc. 2014 Jan;11(1):30-5.
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.
PLoS One. 2014 Jan 21;9(1):e85620.
Risk for uveitis with oral moxifloxacin: a comparative safety study.
JAMA Ophthalmol. 2015 Jan;133(1):81-4.
Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.
Ann Fam Med. 2014 Mar-Apr;12(2):121-7.
Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomizedtrial.
Antimicrob Agents Chemother. 2011 Mar;55(3):1142-7.
The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pyloriinfection: a systematic review and meta-analysis of randomized clinical trials.
Braz J Med Biol Res. 2013 Jul;46(7):607-13.
Primary ethambutol resistance among Iranian pulmonary tuberculosis patients: a systematicreview.
Ther Adv Infect Dis. 2016 Oct;3(5):133-138.
Prevalence and Antibiogram study of Rhodococcus equi in equines of Jammu and Kashmir, India.
J Equine Sci. 2015;26(1):21-4.
Clinical epidemiology and paraclinical findings in tuberculosis patients in north of Iran.
Biomed Res Int. 2015;2015:381572.